One Family, Two Ends of the Life Span: The Pharmacokinetics Behind a Toddler's Ibuprofen Dose and Her Great-Grandfather's Nightly Diphenhydramine
[Student Name]
University of Phoenix
NRP/507: Advanced Pharmacology
Week 2 Assignment
[Instructor Name]
[Date]
The patients are composites written for a model paper.
On one afternoon in our family practice, I saw two members of the same family. Maya, 19 months old and weighing 11 kg, had a fever of 39.1 °C with an ear infection; her mother wanted to know how much ibuprofen to give and had been using an adult product with a kitchen spoon. Mr. D., Maya's 88-year-old great-grandfather, came because his daughter noticed he had become confused at night and had fallen once in the bathroom. He had been taking 50 mg of diphenhydramine at bedtime for sleep for three months. This paper uses pharmacokinetics and pharmacodynamics to explain both situations and the plan for each.
Why Age Changes Drug Handling
Kearns et al. (2003) described how drug disposition changes through infancy and childhood as organs mature, so that children are not small adults in how they absorb, distribute, metabolize and excrete drugs. At the other end of life, Mangoni and Jackson (2004) summarized how aging reduces kidney and liver clearance, changes body composition and increases sensitivity to many drugs. The same dose can therefore mean different things at 19 months and 88 years.
Absorption
In toddlers, gastric emptying and intestinal function are close to adult patterns by this age, and oral ibuprofen is well absorbed (Kearns et al., 2003). The main absorption risk for Maya is not physiology but measurement: a kitchen spoon can hold anywhere from half to twice the intended amount. For Mr. D., aging slows gastric emptying somewhat, but absorption of most oral drugs, including diphenhydramine, is not greatly changed (Mangoni & Jackson, 2004).
Distribution
Total body water makes up a larger share of a toddler's weight than an adult's, enlarging the volume of distribution of water-soluble drugs and is one reason pediatric doses are calculated per kilogram (Kearns et al., 2003). Older adults have less body water and relatively more fat. Diphenhydramine is lipid soluble, so in Mr. D. its volume of distribution rises and its half-life lengthens, allowing the drug to linger into the next day (Mangoni & Jackson, 2004).
Metabolism
By 19 months, many liver enzyme pathways are mature and some work faster per kilogram than in adults, which is why toddlers often need doses per kilogram that are equal to or greater than adult doses per kilogram (Kearns et al., 2003). Ibuprofen is metabolized by the liver and cleared efficiently in children of Maya's age. In Mr. D., liver mass and blood flow decline with age, reducing clearance of drugs that depend on hepatic metabolism, including diphenhydramine (Mangoni & Jackson, 2004).
Excretion
Kidney function matures during the first year of life and is near adult levels, adjusted for size, by Maya's age. Mr. D.'s kidney function has declined: a creatinine of 1.1 mg/dL on his last panel looks unremarkable but, given his age and low muscle mass, reflects reduced clearance. Normal serum creatinine in an older adult can hide substantial loss of function, which is why clearance should be estimated before dosing renally cleared drugs (Mangoni & Jackson, 2004).
Pharmacodynamics
Older adults are more sensitive to drugs acting on the central nervous system, independent of blood levels (Mangoni & Jackson, 2004). Diphenhydramine blocks histamine and muscarinic acetylcholine receptors. In an older brain with reduced cholinergic reserve, this anticholinergic effect can produce confusion, delirium and unsteadiness. The American Geriatrics Society Beers Criteria recommend avoiding first-generation antihistamines in older adults because of these risks (American Geriatrics Society Beers Criteria Update Expert Panel, 2023). Mr. D.'s night confusion and his fall are not signs of a new disease until the sleeping pill has been ruled out as the cause.
Maya's Plan
Maya weighs 11 kg. Ibuprofen at 10 mg/kg is 110 mg per dose. The infant and children's products differ in concentration, so I prescribe the children's suspension at 100 mg per 5 mL and specify 5.5 mL every 6 to 8 hours as needed, not to exceed four doses in 24 hours, measured with the oral syringe that comes with the product. I explain that the adult tablets and kitchen spoons should not be used, that fever itself is not dangerous and that the goal is comfort. I also give her mother a written dosing chart, since the dose will change as Maya grows. The ear infection is managed separately according to current pediatric guidance.
Mr. D.'s Plan
Mr. D.'s diphenhydramine should stop. Because he has taken it nightly for three months, I will reduce it to 25 mg for one week and then stop, to limit rebound insomnia. Sleep hygiene measures, a consistent bedtime, limiting evening fluids to reduce nighttime bathroom trips and a night light in the bathroom address both sleep and falls. I will screen for other causes of confusion, including infection, low sodium and depression, and review his other medications for anticholinergic effects. His daughter will note any nighttime confusion in the two weeks after stopping.
Protein Binding
Protein binding also shifts with age. Ibuprofen is highly bound to albumin, and by Maya's age albumin levels and binding are close to adult values, so the usual dose produces the expected free drug concentration (Kearns et al., 2003). In older adults with low albumin from poor nutrition or illness, highly bound drugs can have a larger free fraction and a stronger effect at the same total level (Mangoni & Jackson, 2004). Mr. D.'s albumin is 3.6 g/dL, low normal, which matters less for diphenhydramine than for drugs such as phenytoin or warfarin but is worth noting as other drugs are reviewed.
Why Over-the-Counter Products Deserve a Prescriber's Attention
Neither patient was harmed by a prescription. Maya's mother reached for the bottle in the medicine cabinet, and Mr. D. bought his sleep aid at the pharmacy counter. Both illustrate that a nurse practitioner's pharmacology knowledge applies to every drug a patient takes, not only the ones the prescriber writes. Asking about over-the-counter products at every visit, by name, is part of safe prescribing at both ends of life.
Teaching Both Families
The teaching differs by age. For Maya's mother, the priorities are the correct product, the right measuring device and the dosing interval. For Mr. D. and his daughter, the priority is that over-the-counter does not mean safe in older adults. I will ask Mr. D.'s daughter to bring every bottle in the house, including sleep aids and cold products, to his next visit, since diphenhydramine appears in many combination products.
Follow-Up
Maya's mother will call if fever persists beyond 72 hours or Maya becomes less responsive. Mr. D. will return in two weeks, when his daughter will report on sleep, confusion and falls.
Conclusion
The same principles of absorption, distribution, metabolism, excretion and receptor sensitivity explain two different prescribing decisions in one family. Maya needs a weight-based dose measured accurately, because children handle drugs efficiently but must be dosed for their size. Mr. D. needs a drug stopped, because age slows clearance and heightens the brain's sensitivity to anticholinergic effects.
References
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. https://doi.org/10.1111/jgs.18372
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003). Developmental pharmacology: Drug disposition, action, and therapy in infants and children. New England Journal of Medicine, 349(12), 1157-1167. https://doi.org/10.1056/NEJMra035092
Mangoni, A. A., & Jackson, S. H. D. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. British Journal of Clinical Pharmacology, 57(1), 6-14. https://doi.org/10.1046/j.1365-2125.2003.02007.x
How this NRP 507 Week 2 example is structured
The NRP/507 Week 2 work usually applies pharmacokinetic and pharmacodynamic principles to patients at different ages. This paper takes each phase of drug handling in turn and applies it to both patients, so the contrast between the youngest and oldest members of one family shows how age changes what a dose does. Students search this week as NRP 507 Week 2, NRP507 Wk 2 or NRP/507 Wk 2; all three are the same assignment.
NRP/507 Week 2 questions, answered
What does NRP/507 Week 2 usually ask for?
Many sections ask students to apply pharmacokinetics and pharmacodynamics to prescribing for children, older adults or other special populations.
Why is diphenhydramine a concern in older adults?
It is strongly anticholinergic, and older adults are more sensitive to its effects, including confusion, constipation, urinary retention and falls. The Beers Criteria list first-generation antihistamines as potentially inappropriate.
How is ibuprofen dosed for young children?
By weight, commonly 10 mg/kg per dose every 6 to 8 hours, with a maximum daily amount, and it is generally not used in infants under 6 months without prescriber direction.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.